You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 尖峯集團四連板 即便澄清稱上海北卡的卡隆酸酐銷量較小 客户均在國內
格隆匯 12-30 10:33
格隆匯12月30日丨尖峯集團(600668.SH)今日迎來連續第四個漲停,報19.33元,總市值67億元。尖峯集團昨晚發佈股票交易異動公吿稱,截至本公吿披露日,子公司上海北卡及其子公司以農藥原藥及中間體為主要業務,中間體主要品種為左氧氟羧酸、氧氟羧酸,卡隆酸酐的銷售量較少,毛利率低,2021年度卡隆酸酐銷售收入約為1260.37萬元,約為公司2020年度銷售總收入的0.39%,銷售客户全部為國內客户,目前上海北卡已不持有“蒈醛酸內酯、卡龍酸、卡龍酸酐及其關鍵中間體的新合成方法”的生產專利。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account